Skip to main content
. 2011 May 4;301(1):R244–R254. doi: 10.1152/ajpregu.00406.2010

Fig. 3.

Fig. 3.

[d-Ala2, N-MePhe4, Gly-ol]-enkephalin (DAMGO) effects on 5% Intralipid consumption after infusion into the nucleus accumbens (NAcc) core (A–C) or shell (D–F). A and D: 5% Intralipid consumption following NAcc DAMGO infusion. Different letters indicate statistically significant differences. Mean ± SE lick rate (B and E) and meal duration (C and F) following NAcc DAMGO infusion. Asterisks indicate significant differences relative to saline control (Sal).